Business
How Moderna went from coronavirus sequence to a phase-1-ready vaccine candidate in 42 Days – Motley Fool Australia
The biotech got a little help from Amazon’s AWS.
Moderna(NASDAQ:MRNA), one of the leaders in the race to develop a coronavirus vaccine, was able to take the initial coronavirus sequence and get a vaccine candidate, mRNA-1273, ready for a phase 1 clinical trial in just 42 days.
The biotech’s use of Amazon Web Services (AWS), the cloud-based computing service run by Amazon (NASDAQ:AMZN), enabled this quick development. Moderna runs its Drug Design Studio on AWS, which allows it to design its mRNA drug candidates quickly.
The potential drugs ar…
-
Noosa News22 hours agoBrisbane doctor jailed for trafficking ‘breathtaking amount’ of drugs
-
General17 hours ago‘We are here for you’: PM to bring help to flood zones
-
General15 hours agoWe’ve all talked about potential economic consequences for Australia of Trump’s policies. Now they’re happening
-
General12 hours agoStephanie Scott’s murder caused a ‘seismic’ shock in Leeton, and the hurt remains